Aurobindo Pharma’s Managing Director resigns
N Govindarajan will be relieved from the services of the company effective from the close of business on 31st December, 2021
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
N Govindarajan
Aurobindo Pharma to make COVAXX’s potential COVID-19 vaccine for India, UNICEF
Aurobindo Pharma said that it would make and sell US-based COVAXX’s COVID-19 vaccine candidate for supply in India and to the…
Aurobindo Pharma to divest Natrol to New Mountain Capital
Aurobindo Pharma has reached a definitive agreement to sell Natrol, a wholly owned subsidiary of Aurobindo Pharma US, to an…
Aurobindo Pharma plans to launch 50-60 products in US in FY21
Aurobindo Pharma's US business posted a growth of 27 per cent year-on-year to Rs 11,484 crore in FY20.
Aurobindo Pharma net surges 39.5 per cent to Rs 636 crore
Revenues stood at Rs 5,444.6 crore against Rs 4,250.3 crore and witnessed a strong growth of 28.1 per cent Aurobindo Pharma has…